Business Standard

Drug regulator to meet again on Jan 1 to discuss AstraZeneca vaccine

India is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany's BioNTech, and by India's Bharat Biotech

Photo: Reuters
Premium

SII, the world's biggest vaccine producer, has already stockpiled about 50 million doses, enough for 25 million people | Photo: Reuters

Reuters New Delhi
New Delhi: India's drug regulator will meet again on Friday to consider approving AstraZeneca and Oxford University's Covid-19 vaccine for emergency use after Britain became the first country to do so, the government said following a meeting on Wednesday.

India wants to start inoculating its citizens next month. It is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany's BioNTech, and by India's Bharat Biotech.
 
India's Ministry of Health and Family Welfare said the country's Central Drugs Standard Control Organization (CDSCO) was analysing trial and other data presented by the AstraZeneca vaccine's local partner and Bharat

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 30 2020 | 9:29 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com